Alberta Expands Coverage for Continuous Glucose Monitoring
Dexcom, Inc. (NASDAQ: DXCM), a leading name in glucose management, is thrilled to announce a significant development in diabetes care. The Alberta government has added the Dexcom G7 Continuous Glucose Monitoring (CGM) System to the Alberta Drug Benefit List. In a major step forward, they have also relaxed age limitations, now including adults aged 18 and older in the eligibility criteria.
Access for Albertans with Type 1 and Type 2 Diabetes
Residents of Alberta living with type 1 or type 2 diabetes can now access coverage for the Dexcom G7 provided they are enrolled in a government-sponsored health benefit plan and meet the eligibility requirements outlined below:
- For those under 18: ongoing use of any form of insulin or insulin pump therapy is required.
- For individuals 18 years and older: the requirement includes the ongoing use of insulin pump therapy, basal and bolus insulin regimens, or premixed insulin.
Transforming Diabetes Management
André Côté, Vice President and General Manager of Dexcom Canada, stated, “Canadians managing any form of diabetes face unique challenges. The Dexcom G7 aims to simplify daily management, whether for a newly diagnosed teenager or an adult managing their condition for years. We believe the Alberta government's decision to provide public coverage significantly benefits residents utilizing intensive insulin therapy.”
The introduction of the Dexcom G7 offers a breakthrough in how individuals handle their glucose levels. Clinical studies show this device effectively reduces A1C levels for both type 1 and type 2 diabetes patients. Its features, including a rapid sensor warm-up period and a predictive Urgent Low Soon alert, distinguish it from other CGM options available in Canada.
Clinical Support for CGM Access
Dr. Peter Senior, an Endocrinologist and Director at the Alberta Diabetes Institute, emphasized the significance of CGM for insulin-dependent individuals. He remarked, “The benefits of CGM technology, as per Canadian and global clinical guidelines, highlight its necessity for effective diabetes management.” This enhanced access to CGM technology is a crucial stride toward equitable healthcare for those in Alberta facing the difficulties of diabetes.
Increased Coverage Across Canada
Over the recent years, Dexcom’s advanced CGM technology has received increasing coverage throughout Canada. The recent decision by Alberta aligns it with provinces such as British Columbia, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island, and Yukon in making diabetes technology more accessible to a larger population.
Albertans using any form of insulin who hold private insurance or are participants in the Non-Insured Health Benefits (NIHB) federal program can access the Dexcom G7 through their respective plans.
Learn More About Dexcom G7
For more information about the Dexcom G7 and specifics regarding insurance plan coverage, kindly visit Dexcom Coverage Information.
About Dexcom
Founded in 1999, Dexcom continues to empower individuals to take control of their health through groundbreaking biosensing technology. With over 25 years of innovation, their devices have transformed diabetes management, guiding patients to monitor their glucose levels effectively and confidently.
For further insights, visit Dexcom Official Site.
Frequently Asked Questions
What is the Dexcom G7 CGM system?
The Dexcom G7 is a continuous glucose monitoring system that helps individuals track their glucose levels in real-time, enhancing diabetes management.
Who is eligible for coverage in Alberta?
Eligibility extends to Alberta residents with type 1 or type 2 diabetes requiring ongoing insulin therapy, including both children and adults.
How does the Dexcom G7 benefit users?
This technology helps users maintain better glucose control, which can lead to improved health outcomes and a better quality of life.
What are the key features of the Dexcom G7?
The Dexcom G7 offers features such as a quick sensor warm-up time, Urgent Low Soon alerts, and compatibility with various digital health applications.
How can I learn more about coverage options?
For comprehensive details about insurance coverage for the Dexcom G7, you can visit the official Dexcom coverage website.
